Materials
The supporting information includes: Chloroplatinic acid hexahydrate (H2PtCl6·6H2O), sodium citrate, NH4F, HF, HNO3, (3-glycidoxypropyl) trimethoxysilane (3-GPS), toluene, ethanol, and centrifugal filter (molecular cutoff: 150,000 Da) were purchased from Sigma-Aldrich (St. Louis, MO, USA). DsRed-conjugated anti-rabbit secondary antibody were purchased from Abcam (Cambridge, UK). Tridecafluoro-1, 1, 2, 2-tetrahydrooctyl-1-trichlorosilane was purchased from Pfaltz and Bauer (Waterbury, CT, USA). Phosphate-buffered saline (PBS) (0.1 M, pH 7.4) was obtained from Lonza (Allendale, NJ, USA). Red ink was purchased from Fisher Scientific (Waltham, MA, USA). Polyvinyl chloride sealing tape was obtained from 3M (St. Paul, MN, USA). Amorphous diamond-coated drill bits (0.031 inch cutter diameter) were purchased from Harvey Tool (Rowley, MA, USA). Photomasks for the devices were designed using AutoCAD software and printed out as transparency photomasks by CAD/Art Services (Bandon, OR, USA) with resolution at 10 µm.
Methods

A. Microfluidic device fabrication
The pattern for the DV-chip was fabricated using a standard photolithography process, [1, 2] with the procedures as shown in Figure S1 . In brief, glass slides (75×50×1 mm) were first spin-coated with a layer (~10 µm) of SPR220-7 photoresist, baked at 75°C for 3 min, and baked again at 110°C for 5 min. After cooling to room temperature, the photoresist-coated glass slides were exposed to UV light for 50 s through a photomask containing the DVchip layout. Slides were then immersed in SPR developer solution (MF-CD26) for 3 min S3 to wash the photoresist off the exposed area. Slides were then thoroughly rinsed with Millipore water and dried with nitrogen gas to create the pattern. Before etching, the backs of the slides were protected with polyvinyl chloride sealing tape to prevent unintentional etching. The glass slides were then immersed in a glass-etching solution (1:0.5:0.75 mol/L HF/NH4F/HNO3) to etch the pattern. Etching was performed in a 35°C water bath to control the etching speed. After 45 min, slides were etched to a depth of ~50 µm. The sealing tape was removed and slides were rinsed with water and acetone and wiped with ethanol cloth.
Finally, holes for sample inlets/outlets were formed with a 0.03-inch diamond drill. For surface modification, the glass slides were first treated with oxygen plasma followed by deposition of 10 µL tridecafluoro-1, 1, 2, 2-tetrahydrooctyl-1-trichlorosilane and drying in a vacuum drier for 2 h. Finally, the glass slides were wiped with ethanol cloth and dried with nitrogen gas.
B. Preparation and conjugation of platinum nanoparticles (PtNPs)
PtNPs were prepared using a method similar to previously reported methods. [3] One milliliter of 1% w/v H2PtCl6 aqueous solution was added to a 250-mL conical flask containing 100 mL water. The solution was heated to boiling, and 3 mL 1% w/v sodium citrate aqueous solution was added rapidly. The mixture was kept at a boil for ~30 min.
PtNPs with average diameter 3.6 nm were synthesized. To produce larger PtNPs, we used 3 mL 1% w/v H2PtCl6 and added 0.33 mL 1% w/v sodium citrate into the boiled solution.
After 30 min, sodium citrate (1% w/v, 2.67 mL) was added into the mixture solution, which was maintained at a boil for 1 h. PtNPs with average diameter 56.2 nm were produced. The size distribution of PtNPs was characterized by dynamic light scattering (Malvern Zetasizer Nano Series, Malvern, UK). The concentration of the PtNP stock solutions were 2.5 mg/mL S4 (~ 720 nM) for 3.6-nm PtNPs and 13.7 mg/mL (~ 1.44 nM) for 56.2-nm PtNPs. We compared the catalytic performance of these two PtNP populations (using 0.1 nM as the concentration for both of them) and found that the 56.2-nm PtNP catalyzed generation of O2 from H2O2 is much more efficiently ( Figure S3 ). Therefore, we used the 56.2-nm PtNPs in subsequent experiments.
To prepare antibody-conjugated PtNPs, 2 µL 1 mg/mL detection antibody was mixed with 200 µL 1 mg/mL PtNPs in PBS and maintained at 4ºC overnight. Antibodies bonded to the surface of PtNPs ( Figure S4 ) by the cleavage of the sulfur-sulfur bond in disulfides through oxidation. [4] Then bovine serum albumin (BSA) was added to final concentration of 1% w/v to block the surface of the PtNPs, and the unconjugated antibody was removed using a centrifugal filter. Finally, the antibody-conjugated PtNPs were suspended in 200 µL 10 mM PBS, pH 7.4, containing 0.1% v/v Triton X-100, 5% w/v sucrose, and 1% w/v BSA. [5] C. Evaluation of the DV-chip 
D. Silane treatment of the surface
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Before the ELISA assay, the surface of the bottom plate must be treated with silane. Briefly, wells of the first lane from the top and bottom ends were cleaned with piranha solution for 1 h, rinsed with Millipore water, and dried with nitrogen gas. Next, 2 µL 10% v/v 3-GPS diluted in toluene was added to each well followed by incubation for 1 h, and wells were washed with fresh toluene to remove excess 3-GPS. The glass slides were then dried with nitrogen gas and baked at 120°C for 30 min. Finally, epoxy groups were covalently bonded to the surface of each well.
[2]
E. Test of antibody coating efficiency on the DV-chip
Before the biomarker test, the coating efficiency of capture antibody on the wet-etched glass surface was tested. After silane treatment, the wet-etched well was coated with rabbit monoclonal antibody to CEA at 4ºC overnight and then blocked with BSA at room temperature for 1 h. DsRed-conjugated anti-rabbit IgG secondary antibody was then added to the well and incubated for 1 h at room temperature. After thorough washing with PBS, the fluorescence image of the well surface was obtained using an EVOS® FL Auto inverted microscopy and a 40× objective (Life Technologies, Grand Island, NY, USA). 
